Parallel Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $126K | Buy |
744
+60
| +9% | +$10.3K | ﹤0.01% | 1448 |
|
|
2025
Q4 | $116K | Sell |
684
-150
| -18% | -$24.4K | ﹤0.01% | 1391 |
|
|
2025
Q3 | $120K | Sell |
834
-300
| -26% | -$41K | ﹤0.01% | 1324 |
|
|
2025
Q2 | $143K | Sell |
1,134
-1
| -0.1% | -$123 | ﹤0.01% | 1174 |
|
|
2025
Q1 | $145K | Sell |
1,135
-104
| -8% | -$14.1K | ﹤0.01% | 1104 |
|
|
2024
Q4 | $164K | Sell |
1,239
-135
| -10% | -$19K | ﹤0.01% | 1017 |
|
|
2024
Q3 | $200K | Hold |
1,374
| – | – | ﹤0.01% | 929 |
|
|
2024
Q2 | $189K | Sell |
1,374
-574
| -29% | -$76.6K | ﹤0.01% | 891 |
|
|
2024
Q1 | $267K | Sell |
1,948
-2,670
| -58% | -$365K | 0.01% | 747 |
|
|
2023
Q4 | $627K | Sell |
4,618
-783
| -14% | -$95.5K | 0.02% | 425 |
|
|
2023
Q3 | $661K | Sell |
5,401
-675
| -11% | -$85.8K | 0.02% | 389 |
|
|
2023
Q2 | $772K | Sell |
6,076
-153
| -2% | -$19.9K | 0.02% | 368 |
|
|
2023
Q1 | $805K | Buy |
6,229
+1,686
| +37% | +$221K | 0.03% | 349 |
|
|
2022
Q4 | $597K | Buy |
4,543
+178
| +4% | +$23K | 0.03% | 357 |
|
|
2022
Q3 | $511K | Buy |
4,365
+218
| +5% | +$27.1K | 0.02% | 384 |
|
|
2022
Q2 | $488K | Buy |
4,147
+190
| +5% | +$22.6K | 0.02% | 402 |
|
|
2022
Q1 | $518K | Sell |
3,957
-324
| -8% | -$42.2K | 0.02% | 416 |
|
|
2021
Q4 | $653K | Sell |
4,281
-48
| -1% | -$7.43K | 0.02% | 367 |
|
|
2021
Q3 | $700K | Sell |
4,329
-31
| -0.7% | -$5.22K | 0.03% | 327 |
|
|
2021
Q2 | $714K | Hold |
4,360
| – | – | 0.03% | 314 |
|
|
2021
Q1 | $656K | Buy |
4,360
+122
| +3% | +$19.4K | 0.03% | 303 |
|
|
2020
Q4 | $642K | Sell |
4,238
-23
| -0.5% | -$3.29K | 0.03% | 283 |
|
|
2020
Q3 | $577K | Sell |
4,261
-549
| -11% | -$74.5K | 0.04% | 275 |
|
|
2020
Q2 | $657K | Buy |
4,810
+1,159
| +32% | +$148K | 0.04% | 246 |
|
|
2020
Q1 | $393K | Sell |
3,651
-75
| -2% | -$8.63K | 0.03% | 297 |
|
|
2019
Q4 | $449K | Buy |
3,726
+554
| +17% | +$61.8K | 0.03% | 308 |
|
|
2019
Q3 | $316K | Hold |
3,172
| – | – | 0.03% | 365 |
|
|
2019
Q2 | $346K | Sell |
3,172
-383
| -11% | -$40.7K | 0.03% | 319 |
|
|
2019
Q1 | $397K | Sell |
3,555
-144
| -4% | -$15.8K | 0.04% | 258 |
|
|
2018
Q4 | $356K | Buy |
3,699
+204
| +6% | +$21.7K | 0.05% | 253 |
|
|
2018
Q3 | $426K | Buy |
3,495
+111
| +3% | +$13.1K | 0.05% | 232 |
|
|
2018
Q2 | $371K | Hold |
3,384
| – | – | 0.05% | 224 |
|
|
2018
Q1 | $361K | Hold |
3,384
| – | – | 0.06% | 225 |
|
|
2017
Q4 | $361K | Hold |
3,384
| – | – | 0.06% | 217 |
|
|
2017
Q3 | $350K | Buy |
3,384
+60
| +2% | +$6.41K | 0.06% | 221 |
|
|
2017
Q2 | $354K | Hold |
3,324
| – | – | 0.07% | 218 |
|
|
2017
Q1 | $328K | Sell |
3,324
-675
| -17% | -$64.6K | 0.07% | 209 |
|
|
2016
Q4 | $354K | Buy |
+3,999
| New | +$364K | 0.08% | 171 |
|
Other funds holding IBB
CB
Parallel Advisors's IBB Position: Q1 2026 in Review
Parallel Advisors increased its iShares Biotechnology ETF (IBB) stake by 8.8% in Q1 2026, buying an estimated $10.3K and bringing the position to 744 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1448.
Parallel Advisors first reported a position in IBB in Q4 2016 and has held it in 38 quarters since. The position peaked at $805K in Q1 2023. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Parallel Advisors held 744 shares of iShares Biotechnology ETF worth $126K as of Q1 2026.
- Parallel Advisors bought 60 iShares Biotechnology ETF shares in Q1 2026, an estimated $10.3K.
- iShares Biotechnology ETF made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #1448 holding.
- Parallel Advisors first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 38 quarters since.
- Parallel Advisors's iShares Biotechnology ETF position peaked at $805K in Q1 2023.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.